These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18828527)

  • 1. Information and consent forms for sublingual immunotherapy.
    Demoly P; André C
    Clin Allergy Immunol; 2008; 21():527-34. PubMed ID: 18828527
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommendations for appropriate sublingual immunotherapy clinical trials.
    Casale TB; Canonica GW; Bousquet J; Cox L; Lockey R; Nelson HS; Passalacqua G
    J Allergy Clin Immunol; 2009 Oct; 124(4):665-70. PubMed ID: 19766297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual immunotherapy for allergic respiratory diseases: efficacy and safety.
    Passalacqua G; Canonica GW
    Immunol Allergy Clin North Am; 2011 May; 31(2):265-77, ix. PubMed ID: 21530819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual specific immunotherapy.
    Mösges R; El Hassan E; Passàli D
    Discov Med; 2010 Oct; 10(53):348-54. PubMed ID: 21034676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Instructions and consent forms for subcutaneous allergen immunotherapy.
    Cox L; Lockey RF
    Clin Allergy Immunol; 2008; 21():499-525. PubMed ID: 18828526
    [No Abstract]   [Full Text] [Related]  

  • 6. [Specific immunotherapy in allergy treatment. Evidence for subcutaneous and sublingual administration].
    Kreutzkamp B
    Med Monatsschr Pharm; 2008 Dec; 31(12):473-7. PubMed ID: 19133596
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-injection routes for immunotherapy of allergic diseases.
    Valovirta E; Passalacqua G; Canonica WG
    Clin Allergy Immunol; 2004; 18():607-23. PubMed ID: 15042938
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety of sublingual immunotherapy.
    Ciprandi G; Marseglia GL
    J Biol Regul Homeost Agents; 2011; 25(1):1-6. PubMed ID: 21382267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Undertreatment of allergy: exploring the utility of sublingual immunotherapy.
    Emanuel IA; Parker MJ; Traub O
    Otolaryngol Head Neck Surg; 2009 May; 140(5):615-21. PubMed ID: 19393398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects associated with sublingual immunotherapy.
    Passalacqua G; Valovirta E
    Clin Allergy Immunol; 2008; 21():469-75. PubMed ID: 18828524
    [No Abstract]   [Full Text] [Related]  

  • 11. An update on the safety of specific immunotherapy.
    Windom HH; Lockey RF
    Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):571-6. PubMed ID: 18978474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual immunotherapy for inhalant allergy: cautious optimism.
    Krouse JH
    Otolaryngol Head Neck Surg; 2009 May; 140(5):622-4. PubMed ID: 19393399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovation in immunotherapy.
    Thomas WR
    Clin Exp Allergy; 2009 Apr; 39(4):450-4. PubMed ID: 19317800
    [No Abstract]   [Full Text] [Related]  

  • 14. Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice.
    Campbell DE
    Paediatr Respir Rev; 2009 Jun; 10(2):69-74; quiz 74. PubMed ID: 19410205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Under the skin or under the tongue: differences and similarities in mechanisms of sublingual and subcutaneous immunotherapy.
    Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA
    Immunotherapy; 2013 Nov; 5(11):1151-8. PubMed ID: 24188667
    [No Abstract]   [Full Text] [Related]  

  • 16. Customized antigens for desensitizing allergic patients.
    Ferreira F; Wallner M; Thalhamer J
    Adv Immunol; 2004; 84():79-129. PubMed ID: 15246251
    [No Abstract]   [Full Text] [Related]  

  • 17. Anaphylaxis to sublingual immunotherapy.
    Dunsky EH; Goldstein MF; Dvorin DJ; Belecanech GA
    Allergy; 2006 Oct; 61(10):1235. PubMed ID: 16942576
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children.
    de Bot CM; Moed H
    Pediatr Allergy Immunol; 2007 Nov; 18(7):627; author reply 628. PubMed ID: 18001435
    [No Abstract]   [Full Text] [Related]  

  • 19. Administration of sublingual vaccines.
    Passalacqua G; Canonica GW
    Clin Allergy Immunol; 2008; 21():333-41. PubMed ID: 18828515
    [No Abstract]   [Full Text] [Related]  

  • 20. LAIS Allergoid.
    Mistrello G
    Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):21-4. PubMed ID: 17761102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.